QELBREE 150 mg/1 (Viloxazine Hydrochloride CAPSULE, EXTENDED RELEASE) 150 mg/1

QELBREE 150 mg is an extended-release capsule containing viloxazine hydrochloride, used for managing certain mental health conditions. This medication is designed to provide sustained relief and is manufactured by Supernus Pharmaceuticals, Inc.

Strength

150 mg/1

Pack Size

90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-90)

Manufacturer / TM Owner

Supernus Pharmaceuticals, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

QELBREE 150 mg is primarily used to address symptoms associated with attention deficit hyperactivity disorder (ADHD). It works by modulating certain neurotransmitters in the brain, which can help improve focus and reduce impulsivity. People often wonder, 'What is QELBREE used for?' and the answer lies in its ability to support mental health by managing ADHD symptoms.

Side Effects

Common effects of QELBREE 150 mg may include changes in appetite, sleep patterns, and mood. Some users report feeling more alert and focused, while others may experience mild gastrointestinal discomfort. These effects can vary from person to person and typically subside as the body adjusts to the medication.

Precautions & Warnings

QELBREE 150 mg should be handled with care, especially for those with a history of heart conditions or high blood pressure. It is important to follow the prescribed guidelines and consult a healthcare provider before starting or stopping the medication. Always store the capsules in a cool, dry place away from direct sunlight.

Avoid Interactions

QELBREE 150 mg may interact with certain medications, including those that affect liver enzymes or other mental health treatments. Alcohol and other central nervous system depressants should be avoided while taking this medication. Always inform your healthcare provider about all the medications you are currently taking to avoid potential interactions.

Frequently Asked Questions

QELBREE 150 mg is used to manage symptoms of attention deficit hyperactivity disorder (ADHD).

QELBREE 150 mg is taken orally, typically once daily, as directed by a healthcare provider.

Common side effects may include changes in appetite, sleep patterns, and mild gastrointestinal discomfort.

QELBREE may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

QELBREE 150 mg should be stored in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.